INSM

Insmed IncorporatedNASDAQHealthcare

$162.43-1.47%ClosedMarket Cap: $35.01B

As of 2026-04-06

Recent Analyst Ratings

Date	Firm	Action	Rating	Previous
2026-04-01	Barclays	—	Overweight	—
2026-03-30	Morgan Stanley	—	Overweight	—
2026-03-26	HC Wainwright & Co.	—	Buy	—
2026-03-25	Mizuho	—	Outperform	—
2026-03-24	Stifel	—	Buy	—
2026-03-24	B of A Securities	—	Buy	—
2026-03-24	Wells Fargo	—	Overweight	—
2026-03-24	Leerink Partners	—	Outperform	—
2026-02-23	HC Wainwright & Co.	—	Buy	—
2026-02-20	Wells Fargo	—	Overweight	—

Forward Estimates

Period	EPS Est.	Revenue Est.	# Analysts
Fri Dec 31	$0.87	$2.76B	13
Sun Dec 31	$4.05	$3.91B	15
Mon Dec 31	$8.43	$5.19B	10
Tue Dec 31	$10.99	$6.47B	6